Thus, this study was designed to identify the molecular mechanism by which VCP regulates NSCLC pathogenesis and also evaluate the therapeutic potential of small-molecule targeting VCP dependent pathways. This evidence concerns the gene VCP and non-small cell lung carcinoma.